Oncology Information Systems Market Size, Share, In-Depth Analysis, Trends and Forecast 2026-2034

According to IMARC Group, the global oncology information systems market size reached USD 4.4 Billion in 2025 and is projected to reach USD 7.4 Billion by 2034, exhibiting a growth rate (CAGR) of 5.71% during 2026–2034. This trajectory reflects the rising global cancer burden, accelerating digitization of oncology departments, the integration of artificial intelligence and blockchain into clinical record management, and expanding government investment in remote cancer monitoring infrastructure.

Oncology Information Systems Industry Overview

An oncology information system is a comprehensive information and image management solution designed to support cancer diagnosis, optimize patient profiling, and identify the most suitable therapeutic pathway in order to improve survival outcomes. These platforms span the full continuum of cancer care — screening, prevention, analysis, treatment, and palliative care — within a unified digital environment.

Compared with conventional paper-based or fragmented departmental systems, oncology information systems offer remote access, structured treatment planning, predictive analytics, and disciplined management of both clinical and non-clinical acquired data. Because OIS platforms track diagnostic detail alongside treatment patterns over time, they are extensively deployed across clinics, laboratories, hospitals, and research centres.

Core functional areas include:

• Patient information management: Consolidated electronic health records, staging data, pathology and imaging results, and longitudinal treatment histories
• Treatment planning: Radiation dose planning, chemotherapy regimen scheduling, multidisciplinary tumour board coordination, and protocol adherence tracking
• Workflow and scheduling: Linac and imaging suite utilization, appointment sequencing, and departmental resource allocation
• Clinical decision support: Evidence-based protocol libraries, AI-assisted contouring and outcome prediction, and alerting for dose or interaction risks
• Research and registry reporting: Clinical trial matching, outcomes registries, and regulatory and quality reporting across cancer programmes

Global Oncology Information Systems Market Size & Key Statistics

The following key statistics are drawn from IMARC Group's comprehensive research report:

Base Year - 2025

Historical Period - 2020–2025

Forecast Period - 2026–2034

Oncology Information Systems Market Size in 2025 - USD 4.4 Billion

Market Forecast in 2034 - USD 7.4 Billion

Market Growth Rate (2026–2034) - 5.71% CAGR

Largest Region - North America

Leading Product and Services Segment - Software

Leading Application - Medical Oncology

Leading End User - Hospitals and Diagnostic Imaging Centers

Request a Free Sample Report for a Detailed Oncology Information Systems Market Analysis: https://www.imarcgroup.com/oncology-information-systems-market/requestsample

Key Drivers and Oncology Information Systems Market Trends in 2026

Several structural forces are shaping Oncology Information Systems Market Trends and underpinning growth expectations through the forecast period:

1. Rising Global Cancer Prevalence and an Ageing Population

The increasing incidence of cancer — particularly among the expanding geriatric population, and driven by tobacco consumption and evolving lifestyle patterns — is the primary demand driver. Higher patient volumes translate directly into greater data complexity per cancer centre, making structured information systems a clinical necessity rather than an administrative convenience.

2. Electronic Health Record Integration Across Cancer Care

OIS platforms maintain electronic health records that improve patient-centred service delivery, generate new insight into disease mechanisms, support earlier detection of disease spread, and enable better-informed treatment selection. Interoperability between OIS, radiology, pathology, and hospital EHR systems has become a defining procurement criterion.

3. Adoption of Artificial Intelligence and Blockchain

Significant technological advancement — including the integration of blockchain and artificial intelligence to mitigate errors in paper-based record creation, prescriptions, and treatment plans — is acting as a major growth-inducing factor. AI-assisted contouring, auto-planning, and outcome prediction are moving from pilot programmes into routine departmental workflows.

4. Government Funding for Remote Oncology Platforms

Governments across multiple countries are funding research and development to introduce remote oncology information systems that allow practitioners to conduct long-term cancer monitoring through mobile applications without being physically present with the patient. This has intensified adoption across the healthcare sector, a trend that accelerated markedly during the COVID-19 period and associated lockdowns.

5. Growth in Radiation and Immunotherapy Volumes

Escalating uptake of oncology information systems to support immunotherapy and radiation therapy delivery is creating a positive market outlook. Radiation oncology in particular depends on tightly coupled planning, dose verification, and record-and-verify functionality that only a dedicated OIS can deliver at scale.

6. Rising Patient and Provider Awareness

Growing awareness of the availability of cancer monitoring systems among patients and providers is expanding the addressable base beyond large academic centres into community oncology practices and regional cancer care networks.

7. Shift Toward Cloud-Based and Subscription Deployment

Cancer centres are increasingly favouring hosted deployments that lower upfront capital requirements, simplify version control, and support multi-site networks. This shift is also enlarging the services layer — consulting, implementation, and maintenance — as an ongoing revenue stream alongside licensed software.

Checkout Now: https://www.imarcgroup.com/checkout?id=5898&method=5011

Key Market Segmentation

IMARC Group provides an analysis of the key trends in each sub-segment of the global market, with forecasts at the global, regional, and country level from 2026–2034. The market has been categorized on the basis of product and services, application, and end user.

By Product and Services

Software – Largest Segment

Software accounts for the majority of the global market share. This segment covers patient information systems, which consolidate demographics, staging, pathology, imaging, and longitudinal treatment histories into a single oncology record, and treatment planning systems, which manage radiation dose planning, chemotherapy regimen construction, and protocol-driven scheduling. The stickiness of clinical software — combined with multi-year licensing and upgrade cycles — sustains its leading position.

Services

The services segment spans consulting services covering workflow assessment and system selection, implementation services covering data migration, integration, and clinical go-live support, and maintenance services covering upgrades, validation, and ongoing technical support. As deployments grow more complex and more multi-site, services represent an increasingly significant share of total programme spend.

By Application

Medical Oncology – Largest Application

Medical oncology currently holds the largest market share. Chemotherapy, targeted therapy, and immunotherapy regimens require meticulous cycle scheduling, dose calculation, toxicity tracking, and response assessment — workflows that benefit most directly from structured digital management and protocol libraries.

Radiation Oncology

Radiation oncology remains a foundational application, where OIS platforms deliver treatment planning integration, record-and-verify functionality, dose accumulation tracking, and linear accelerator scheduling. The tight coupling between planning software and delivery hardware makes this application a key battleground for vendors with both device and software portfolios.

Surgical Oncology

Surgical oncology applications support pre-operative planning, theatre scheduling, multidisciplinary tumour board coordination, and post-surgical pathology and recurrence tracking — connecting the surgical episode to the wider longitudinal cancer record.

By End User

Hospitals and Diagnostic Imaging Centers – Largest End User

Hospitals and diagnostic imaging centers exhibit clear dominance in the market. These institutions manage the highest patient throughput, operate the broadest range of treatment modalities, and carry the strongest regulatory and accreditation reporting requirements — all of which favour comprehensive enterprise-grade OIS deployments.

Ablation Care Centers and Cancer Care Centers

Dedicated cancer care and ablation centres represent a fast-developing end-user group, adopting specialized OIS configurations tuned to focused treatment portfolios and high-volume, protocol-driven care pathways.

Government Institutions

Public health bodies and government-run cancer programmes deploy OIS platforms to support national screening initiatives, cancer registries, epidemiological surveillance, and population-level outcome reporting.

Research Facilities

Research institutions use oncology information systems for clinical trial patient matching, structured data capture, biomarker and outcome correlation, and translational research spanning multiple study cohorts.

Regional Oncology Information Systems Market Analysis

North America – Largest: United States and Canada; advanced oncology infrastructure, high per-capita cancer treatment spending, mature EHR interoperability mandates, strong presence of leading OIS vendors and comprehensive cancer centre networks

Europe: Germany, France, United Kingdom, Italy, Spain, Russia; national cancer plans and public health system digitization, strict data governance requirements, and established radiotherapy networks driving planning system upgrades

Asia-Pacific: China, Japan, India, South Korea, Australia, Indonesia; rapid hospital infrastructure expansion, rising cancer incidence, national health mission funding, and growing radiotherapy and oncology centre capacity

Latin America: Brazil, Mexico; expanding private hospital oncology capacity, growing public cancer care coverage, and increasing investment in digital health infrastructure

Middle East and Africa: Healthcare modernization programmes, new specialty cancer centre construction, and rising demand for integrated oncology data management across the region

North America currently dominates the global market, supported by a dense installed base of comprehensive cancer centres, high adoption of integrated electronic health records, substantial per-patient technology spending, and the headquarters presence of several leading oncology software and radiotherapy vendors. Asia-Pacific represents a significant growth frontier, driven by expanding cancer centre construction, rising diagnostic capacity, and national programmes aimed at broadening access to structured cancer care.

Leading Players in the Global Oncology Information Systems Industry

The competitive landscape blends radiotherapy equipment manufacturers with integrated software portfolios, diversified healthcare technology multinationals, and specialist clinical information system vendors. Key companies covered in the IMARC Group report include:

• Accuray Incorporated
• Advanced Data Systems
• CureMD
• Elekta
• EndoSoft
• Koninklijke Philips N.V
• McKesson Corporation
• MICA Information Systems, Inc.
• Oracle Corporation
• Varian (Siemens Healthineers Company)

Connect for a Detailed Oncology Information Systems Market Analysis – Speak to an Analyst: https://www.imarcgroup.com/request?type=report&id=5898&flag=C

About Us

IMARC Group is a leading global market research company providing data-driven insights and expert consulting services to businesses seeking to achieve their strategic objectives. With a multi-disciplinary team of industry experts, IMARC delivers thorough, reliable market intelligence across sectors including Healthcare, Technology, Chemicals, Energy, Food & Beverages, and more.

Contact Us

IMARC Group

United States: +1-201-971-6302

India: +91-120-433-0800

United Kingdom: +44-753-714-6104